Dror Ortho-Design, Inc. Liquidation Value

DROR Dental Equipment & Supplies

Cash & Equivalents

$23,802
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $23,802
Total Obligations: -$3.38M
$-3.36M
Per share: $-0.00
Period: 2026-03-31
incomplete 3 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported
  • Operating Lease Liability: not reported

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $23,802
AR: N/A
Total Obligations: -$3.38M
$-3.36M
Per share: $-0.00
Period: 2026-03-31
incomplete 4 components missing — treated as $0 in formula. Why?
  • Accounts Receivable: not reported in this period (annual-only)
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported
  • Operating Lease Liability: not reported

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $23,802
AR: N/A
Inventory: N/A
Total Obligations: -$3.38M
$-3.36M
Per share: $-0.00
Period: 2026-03-31
incomplete 5 components missing — treated as $0 in formula. Why?
  • Accounts Receivable: not reported in this period (annual-only)
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported
  • Inventory: not reported
  • Operating Lease Liability: not reported

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-3.36M$-0.00
Liquid Liquidation Value$-3.36M$-0.00
Operating Liquidation Value$-3.36M$-0.00

Key Components (as of 2026-03-31)

Note: Financial institutions (banks, REITs, insurance companies) use specialized accounting standards that differ from standard GAAP balance sheet presentation. Liquidation metrics may not apply and are shown as N/A where data is unavailable. See our methodology page for details.

Data as of 2026-03-31 from 10-Q filed 2026-05-13. View on SEC EDGAR →

Cash & Equivalents$23,802
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$3.38M
Long-term Debt (?)N/A
Op. Lease Liability (?)N/A
Finance Lease (?)N/A
Shares Outstanding977.0M

Explore all 64 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$23,802N/AN/A$101,747$3.38MN/AN/AN/A
2025-12-31$228,540N/AN/A$113,585$2.96MN/AN/AN/A
2025-09-30$240,362N/AN/A$447,250$2.42MN/AN/AN/A
2025-06-30$64,481N/AN/A$405,859$1.64MN/AN/AN/A
2025-03-31$349,851N/AN/A$247,744$1.23MN/AN/AN/A
2024-12-31$549,444N/AN/A$215,359$906,738N/AN/AN/A
2024-09-30$1.14MN/AN/A$84,680$887,888N/AN/AN/A
2024-06-30$1.83MN/AN/A$94,338$257,926N/AN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-13 View
2025-12-31 10-K 2026-02-27 View
2025-09-30 10-Q 2025-11-18 View
2025-06-30 10-Q 2025-08-14 View
2025-03-31 10-Q 2025-05-15 View
2024-12-31 10-K 2025-02-19 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-Q 2024-08-14 View

AI Insights

AI Insight·Generated 2026-05-14

Dror Ortho-Design, Inc. (DROR) is a pre-revenue orthodontic device developer carrying a deeply negative liquidation posture as of March 31, 2026. Total assets of $253,781 sit against total liabilities of $3,566,158, producing a GAAP stockholders' deficit of $(3,312,377). Under the liquidation lens, the asset side is essentially all cash and near-cash: $23,802 in cash (recoverable at 100%) and $211,131 in receivables and prepaid expenses, of which $200,000 is a prepayment of stock issued to AAFE for marketing services not yet commenced — this item has no cash recovery value on liquidation and should be written to zero. PP&E of $18,848 might recover $9,000-$13,000 at 50-70%. Adjusted liquidation asset recovery is therefore approximately $23,802 (cash) plus $11,131 (residual prepaid/receivables at 90-95%, excluding the AAFE prepayment) plus $9,000-$13,000 (PP&E) — total approximately $44,000-$48,000. Against this, liabilities at face value total $3,566,158, consisting of: accounts payable $101,747; accrued expenses $383,584 (including $153,380 of accrued executive salaries); convertible promissory notes at carrying value $1,584,358 (principal $1,950,000 net of $365,642 discount — under liquidation, the full principal face value of $1,950,000 applies, not the discounted carrying value, materially worsening recovery); derivative liability $789,788; Registration Rights Agreement liability $520,000 (no stated repayment date, non-interest-bearing, but face-value obligation on wind-up); and accrued severance $186,681. Using face principal on the debentures, liquidation liabilities are approximately $3,182,000 current plus $186,681 non-current, totaling roughly $3.93 million. Equity recovery to common is deeply negative at approximately $(3.88) million on an adjusted basis. The MFFAIS CLV/LLV/OLV are all reported at $(2,499,474), consistent directionally but understating the severity because they do not appear to gross up the convertible debt discount to face principal. Cash of $23,802 as of March 31, 2026 covers less than two weeks of operating cash burn ($404,268 for Q1 2026). The company is wholly dependent on continued bridge financing — $275,000 in additional debentures closed April 28, 2026 (subsequent event). Accumulated deficit is $22,690,209. Going concern language is explicit. The filing does not separately tag the IIA contingent royalty obligation of approximately $1.25 million in XBRL; this contingent liability appears only in Note 7 narrative — it is sales-contingent and would not crystallize in a wind-up absent prior revenues. The $200,000 AAFE prepayment is tagged as PrepaidExpenseAndOtherAssetsCurrent but is economically a sunk cost under liquidation (services not yet rendered, no cash recovery path). Comparison to the prior 10-K (December 31, 2025): total liabilities increased from $3,132,647 to $3,566,158 (+$433,511) in a single quarter, driven by convertible note principal growth ($1.75M to $1.95M), accrued expense accretion, and derivative liability increase, while assets declined marginally ($258,936 to $253,781). The deterioration in liquidity is the dominant change from the prior period.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...